Extensively hydrolyzed whey infant formula
OtherNew hydrolyzed infant formula.
Other names: Baby Formula
NCT Number: NCT01210391
The primary objective of the clinical trial is to compare growth in infants (expressed as weight gain in g/day) consuming a new extensively hydrolyzed formula (EHF) to infants consuming a commercially available EHF.
Looking for future studies?
Notify Me11 day–4 month
All sexes
Interventional
Not applicable
Colorado Springs Health Partners, Colorado Springs, Colorado, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
New hydrolyzed infant formula.
Other names: Baby Formula
Commercially available infant formula.
Other names: Baby Formula
Time frame: 4 Months
Mean weight gain (g/day) from enrollment to 4 months of age.
Société des Produits Nestlé (SPN)
Industry
Assessment of Growth of Infants Fed a 100% Whey Extensively Hydrolyzed Formula.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06312059
Growth
New York, United States
View Trial DetailsNCT04316221
Development; Delayed, Growth
Tecpán Guatemala, Departamento de Chimaltenango, Guatemala
View Trial DetailsNCT07302477
Adverse Event, Growth
Chak Four Hundred Fifty-four, Pakistan
View Trial DetailsNCT07296718
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Feeding Intolerance
Bahawalpur, Punjab Province, Pakistan
View Trial Details